Global Benign Prostatic Hyperplasia (BPH) Drugs Market Study 2016-2026, by Segment (Alpha-blocker, Phosphodiesterase Type-5 Inhibitors, … …), by Market (Hospitals, Clinics, … …), by Company (Astellas Pharma, Eli Lilly, … …)

• RnM3788240
|
• 27 September, 2019
|
• 61 Pages
|
• 99Strategy
|
• Other